Microarray analysis of the hypoxia-induced gene expression profile in malignant C6 glioma cells

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 9, 2012, Pages 4793-4799

  Huang, Xiao Dong ^a   Wang, Ze Fen ^b   Dai, Li Ming ^a   Li, Zhi Qiang ^c  

^a Department of Neurosurgery ^*  (China)

^b WUHAN UNIVERSITY   (China)

^c ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Differentially expressed genes; Glioma; Hypoxia; Microarray

Indexed keywords

EID: 84874004267     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.9.4793     Document Type: Article

References (28)

1. Bar EE, Lin A, Mahairaki V, et al (2010). Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol, 177, 1491-502.
2. Cooper LA, Gutman DA, Long Q, et al (2010). The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas. PLoS One, 5, e12548.
3. Dai M, Cui P, Yu M, et al (2008). Melatonin modulates the expression of VEGF and HIF-1 alpha induced by CoCl2 in cultured cancer cells. J Pineal Res, 44, 121-6.
4. Di Matteo P, Arrigoni GL, Alberici L, et al (2011). Enhanced expression of CD13 in vessels of inflammatory and neoplastic tissues. J Histochem Cytochem, 59, 47-59.
5. Du R, Lu KV, Petritsch C, et al (2008). HIF-1 alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell, 13, 206-20.
6. Eckerich C, Zapf S, Fillbrandt R, et al (2007). Hypoxia can induce c-Met expression in glioma cells and enhance SF/ HGF-induced cell migration. Int J Cancer, 121, 276-83.
7. Fujiwara S, Nakagawa K, Harada H, et al (2007). Silencing hypoxia-inducible factor-1α inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Int J Oncol, 30, 793-802.
8. González A, Kageyama R (2010). Automatic reconstruction of the mouse segmentation network from an experimental evidence database.Biosystems, 102, 16-21.
9. Ha E, Han E, Park HJ, et al (2006). Microarray analysis of transcription factor gene expression in melatonin-treated human peripheral blood mononuclear cells. J Pineal Res, 40, 305-11.
10. Henke RM, Meredith DM, Borromeo MD, et al (2009).Ascl1 and Neurog2 form novel complexes and regulate Delta-like3 (Dll3) expression in the neural tube. Dev Biol, 328, 529-40.
11. Iizuka K, Horikawa Y (2008). ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. Endocr J, 55, 617-24.
12. Jones DT, Mulholland SA, Pearson DM, et al (2011). Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts. Acta Neuropathol, 121, 753-61.
13. Kern W, Kohlmann A, Schoch C, et al (2006). Comparison of mRNA abundance quantified by gene expression profiling and percentage of positive cells using immunophenotyping for diagnostic antigens in acute and chronic leukemias. Cancer, 107, 2401-7.
14. Kolenda J, Jensen SS, Aaberg-Jessen C, et al (2011). Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids. J Neurooncol, 103, 43-58.
15. Kumar Y, Mazurek S, Yang S, et al (2010). In vivo factors influencing tumour M2-pyruvate kinase level in human pancreatic cancer cell lines. Tumour Biol, 31, 69-77.
16. Li Z, Wang J, Gong L, et al (2011). Correlation of Delta-like Ligand 4 (DLL4) with VEGF and HIF-1alpha Expression in Human Glioma. Asian Pac J Cancer Prev, 12, 215-8.
17. Luo W, Hu H, Chang R, et al (2011). Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell, 145, 732-44.
18. Mawrin C, Wolke C, Haase D, et al (2010). Reduced activity of CD13/ aminopeptidase N (APN) in aggressive meningiomas is associated with increased levels of SPARC. Brain Pathol, 20, 200-10.
19. Onishi M, Ichikawa T, Kurozumi K, et al (2011). Angiogenesis and invasion in glioma. Brain Tumor Pathol, 28, 13-24.
20. Phillips HS, Kharbanda S, Chen R, et al (2006). Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell, 9, 157-73.
21. Potolicchio I, Carven GJ, Xu X, et al (2005). Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J Immunol, 175, 2237-43.
22. Ravanpay AC, Hansen SJ, Olson JM (2010). Transcriptional inhibition of REST by NeuroD2 during neuronal differentiation. Mol Cell Neurosci, 44, 178-89.
23. Rostomily RC, Bermingham-McDonogh O, Berger MS, et al (1997). Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors. Cancer Res, 57, 3526-31.
24. Shimizu T, Uehara T, Nomura Y (2004). Possible involvement of pyruvate kinase in acquisition of tolerance to hypoxic stress in glial cells. J Neurochem, 91, 167-75.
25. Vlashi E, Lagadec C, Vergnes L, et al (2011). Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci, 108, 16062-7.
26. Westerman BA, Poutsma A, Maruyama K, et al (2002). The proneural genes NEUROD1 and NEUROD2 are expressed during human trophoblast invasion. Mech Dev, 113, 85-90.
27. Winnicka B, O'Conor C, Schacke W, et al (2010). CD13 is dispensable for normal hematopoiesis and myeloid cell functions in the mouse. J Leukoc Biol, 88, 347-59.
28. Xu X, Li Z, Wen Z (2010). Glioma-conditioned medium blocks endothelial cells' apoptosis induced by hypoxia and promotes its angiogenesis via up-regulation of uPA/ uPAR. Chin J Cancer Res, 21, 119-25.